Cognitive effects of antipsychotic agents in persons with traumatic brain injury

Brain Injury

Volumn 11, Issue 5, 1997, Pages 335-342

  Stanislav, Steven W ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE;

ADULT; ARTICLE; ATTENTION; BEHAVIOR DISORDER; BRAIN INJURY; CASE REPORT; COGNITION; CONTROLLED STUDY; DRUG WITHDRAWAL; HUMAN; LEARNING; MALE; MEMORY; PSYCHOSIS; SKILL;

EID: 0030963422     PISSN: 02699052     EISSN: None     Source Type: Journal    
DOI: 10.1080/026990597123494     Document Type: Article

References (22)

1. SCHACTER, D. L. and CROVITZ, H. F.: Memory function after closed head injury: a review of the quantitative. Cortex, 13: 150-176, 1977.
2. RUFF, R. M., YOUNG, D., GAUTILLE, T. et al.: Verbal learning deficits following severe head injury: heterogeneity in recovery over 1 year. Journal of Neurosurgery, 75, S50-S58, 1991.
3. STRATTON, M. C. and GREGORY, R. J.: After traumatic brain injury: a discussion of consequences. Brain Injury, 8: 631-645, 1994.
4. VOGENTHALER, D. R.: An overview of head injury: its consequences and rehabilitation. Brain Injury, 1: 113-127, 1987
5. CLIFTON, G., ZIEGLER, M. and GRISSMAN, R.: Circulating catecholamines and sympathetic activity after head injury. Neurosurgery, 8: 10-14, 1981.
6. BAREGGI, S. R., PORTA, M., SELENATI, A. et al.: Homovanillic acid and 5-hydroxyindole-acetic acid in the CSF of patients after a severe head injury. European Neurology, 13, 524-528, 1975.
7. BAKAY, R., SWEENEY, K. and WOOD, J.: Pathophysiology of cerebrospinal fluid in head injury. Neurosurgery, 18: 234-241, 1986.
8. SEEMAN, P.: Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261: 717, 1976.
9. HASHER, L. and ZACKS, R. T.: Autonomie and effortful processes in memory. Journal of Experimental Psychology, 108: 356-362, 1979.
10. WEINGARTNER, H., BURNS, S., DIEBEL, R. et al.: Cognitive impairments in Parkinson's disease. Psychiatry Research, 1: 223-235, 1984.
11. NEWMAN, R. P., WEINGARTNER, H., SMALLBERG, S. A. et al.: Effortful and automatic memory: effects of dopamine. Neurology, 34: 805-807, 1984.
12. PARROT, A. C.: Transdermal scopolamine: effects of single and repeated patches upon psychological task performance. Neuropsychology, 17: 53-59, 1987.
13. GROBER, E., LEIPZIG, R. M., LIPTON, R. B. et al.: Does scopolamine directly impair memory? Journal of Cognitive Neuroscience, 1: 327-335, 1989.
14. SUNDERLAND, T., JARIOT, P. N., COHEN, R. M. et al.: Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched control. Archives of General Psychiatry, 44: 418-426, 1987.
15. TUNE, L. E., STRAUS, M. E., LEW, M. F. et al.: Serum levels of anticholinergic drugs and impaired recent memory inchronic schizophrenic patients. American Journal of Psychiatry, 139: 1460-1462, 1982.
16. PERLICK, D., STASTNY, P. and KATZ, I.: Memory deficits and anticholinergic levels in chronic schizophrenia. American Journal of Psychiatry, 143: 230-232, 1986.
17. SYNDULKO, K., GILDEN, E. R., HANSCH, E. C. et al.: Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients. International Journal of Neuroscience, 14: 61-66, 1981.
18. McLEAN, A. Jr, STANTON, K. M., CARDENAS, D. D. et al.: Memory training combined with the use of oral physostigmine. Brain Injury, 1: 145-159, 1987.
19. CARDENAS, D. D., MCLEAN, A., FARRELL-ROBERTS, L. et al.: Oral physostigmine and impaired memory in adults with brain injury. Brain Injury, 8: 579-587, 1994.
20. DANIEL, D. G.: Comparison of risperidone and clozapine on clinical and cognitive functions in psychotic disorders. Biological Psychiatry, 35: 667, 1994.
21. HAGGAR, C., BUCKLEY, P., KENNY, J. T. et al.: Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34: 702-712, 1993.
22. SPOHN, H. E. and STRAUSS, M. E.: Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology, 58: 367-380, 1989.